Press Release: ZeptoMetrix : ZeptoMetrix Launches Recombinant Monkeypox Virus Stock
The new ZeptoMetrix® Recombinant Monkeypox Stock is intended to aid laboratories in the evaluation of nucleic acid tests designed to detect certain portions of the Monkeypox virus genome.(PRWeb August 25, 2022)Read the full story at https://www.prweb.com/releases/zeptometrix_launches_recombinant_monkeypox_virus_stock/prweb18862286.htm
Read full article »
ZMC is a biotechnology company that manufactures and distributes microorganism control products for research, pharmaceutical and diagnostic purposes.
Read more